Collaboration, License and Option Agreements - Additional Information (Details) - USD ($)		3 Months Ended		12 Months Ended
	Nov. 18, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2019	Dec. 31, 2022
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaboration Amendment Date				2019-03
Revenues		$ 0	$ 0
Liability to licensor		$ 19,806,000			$ 19,806,000
BeiGene
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaboration Amendment Date		2021-11
Upfront Non-Refundable Payment				$ 25,000,000.0
Revenues		$ 0	$ 0
Current portion of deferred revenue	$ 19,800,000
License termination information, Description	In the event the license is terminated, the liability will be extinguished with no further payment to BeiGene.
Liability to licensor		$ 19,800,000			$ 19,800,000